In November 2025, 12% of adults reported that they were taking a GLP-1 drug a 6% increase from 18 months earlier, KFF reported
Proprietary Flatter Me Enzyme Blend 125mg Diastase* * Manufacturer does not disclose amount
Studies have shown (83) reported that GLP-1R is highly expressed in normal pancreatic secretory cells, expressed at low level in pancreatic acinar cells, not expressed in pancreatic duct cells, and expressed at low or no levels in human pancreatic cancer tissues
As prescribing rates climb, awareness of GLP-1 dermatologic effects becomes essential for safe and informed practice
These services are essential to making treatment safe, effective, and sustainable
Theyll guide you based on your unique story.